Federal antitrust enforcement agencies continue to challenge
transactions in the health industry that they view as
anticompetitive. This newsletter provides an update on recent
public comments by government officials overseeing antitrust
enforcement in the health industry and outlines some of the key
steps that parties to certain types of transactions with potential
competitive implications in the health industry should take to
position themselves for defending against a government review.
Health Antitrust Enforcement Update
On May 3 and 4, 2012, representatives from the Federal Trade
Commission (FTC) and U.S. Department of Justice (DOJ)
(collectively, Agencies) gathered at the bi-annual Antitrust in
Healthcare Conference (Conference) co-sponsored by the American Bar
Association and the American Health Lawyers Association.
Collectively, they confirmed the Agencies' commitment to
antitrust enforcement in the health care industry.
